Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Gili Halfteck

Concepts (60)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
3
2024
1181
0.690
Why?
Gallbladder Neoplasms
1
2019
7
0.660
Why?
Adenoma
1
2019
111
0.590
Why?
Adenocarcinoma
1
2019
402
0.490
Why?
Neoplasm Invasiveness
2
2024
268
0.370
Why?
Natural Cytotoxicity Triggering Receptor 1
1
2009
4
0.330
Why?
Antigens, Ly
1
2009
11
0.330
Why?
Cytotoxicity, Immunologic
1
2009
56
0.320
Why?
Killer Cells, Natural
1
2009
107
0.310
Why?
Lymphoma
1
2009
65
0.310
Why?
Laparoscopy
2
2022
170
0.280
Why?
Retrospective Studies
6
2024
6106
0.250
Why?
Mastectomy
2
2023
141
0.250
Why?
Parathyroid Neoplasms
1
2024
27
0.230
Why?
Axilla
1
2024
89
0.230
Why?
Neoplasm Staging
2
2024
748
0.230
Why?
Neoplasm Recurrence, Local
3
2024
627
0.230
Why?
Radiotherapy, Adjuvant
1
2023
60
0.220
Why?
Sentinel Lymph Node Biopsy
1
2024
117
0.220
Why?
Lymph Node Excision
1
2024
137
0.220
Why?
Neoadjuvant Therapy
1
2024
117
0.220
Why?
Intestinal Fistula
1
2022
10
0.200
Why?
Mammaplasty
1
2022
44
0.200
Why?
Lymph Nodes
1
2023
261
0.190
Why?
Crohn Disease
1
2022
90
0.190
Why?
Prospective Studies
1
2023
2341
0.140
Why?
Infant, Newborn
1
2023
2725
0.130
Why?
Cushing Syndrome
1
2014
11
0.120
Why?
Adrenalectomy
1
2014
35
0.120
Why?
Adrenal Glands
1
2014
40
0.120
Why?
Pheochromocytoma
1
2014
36
0.120
Why?
Adrenal Gland Neoplasms
1
2014
52
0.120
Why?
Female
6
2024
26520
0.110
Why?
Humans
7
2024
49863
0.110
Why?
Postoperative Complications
2
2022
1000
0.100
Why?
Survival Rate
2
2024
904
0.100
Why?
Follow-Up Studies
2
2024
2174
0.080
Why?
Flow Cytometry
1
2009
473
0.070
Why?
Mice, Knockout
1
2009
842
0.070
Why?
Parathyroidectomy
1
2024
46
0.060
Why?
Chemotherapy, Adjuvant
1
2024
121
0.060
Why?
Adult
3
2024
13325
0.060
Why?
Lymphatic Metastasis
1
2024
226
0.060
Why?
Middle Aged
3
2024
12258
0.050
Why?
Ileum
1
2022
86
0.050
Why?
Colon
1
2022
96
0.050
Why?
Insurance Coverage
1
2022
109
0.050
Why?
Aged
2
2024
9434
0.050
Why?
Prognosis
1
2024
1948
0.040
Why?
Prevalence
1
2022
951
0.040
Why?
Mice
1
2009
5671
0.040
Why?
Healthcare Disparities
1
2022
277
0.040
Why?
Treatment Outcome
2
2022
5165
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
993
0.040
Why?
Male
3
2024
25439
0.030
Why?
Israel
1
2014
9
0.030
Why?
Comparative Effectiveness Research
1
2014
44
0.030
Why?
Neoplasm Metastasis
1
2014
235
0.030
Why?
Animals
1
2009
13133
0.030
Why?
Reproducibility of Results
1
2014
1180
0.020
Why?
Halfteck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_